Diabetes Clinical Trial
Official title:
Diabetes Prevention With Lifestyle Intervention and Metformin Escalation
Specific Aim: Implement an evidence-based diabetes prevention pragmatic trial for high risk
pre-diabetic individuals of Caribbean-descent to reduce the incidence of diabetes.
Hypothesis: This study seeks to test the hypothesis that implementation of a lifestyle
intervention, with escalation to Metformin therapy will lower the incidence of diabetes among
the highest risk pre-diabetic individuals of Caribbean-descent.
The investigators propose to conduct a pragmatic trial that tests the effectiveness of
lifestyle modification and Metformin use in minority populations. Our study population is
Caribbean-descent individuals in Region 2, Trinidad and Barbados. The investigators will have
five clinical intervention sites situated in New York - 2, Puerto Rico -1, Barbados -1,
Trinidad -1 and US Virgin Islands -1. These sites were chosen because of the investigators'
strong research network in these locations, and to enable us to address diabetes disparities
due to geographic differences. The investigators will first modify an established lifestyle
modification workshop series developed by the East Harlem Partnership for Diabetes Prevention
(EHPDP) for use in the community, 10to target the population at the involved clinical sites.
The investigators plan to adapt the D-CLIP protocol and escalate to Metformin therapy for the
highest risk pre-diabetic patients whose hemoglobin A1c (HbA1c) has not improved or who
remain morbidly obese.
The investigators will leverage our existing robust research infrastructure and network at
the five sites through our Eastern Caribbean Health Outcomes Research Network (ECHORN) and
now the Yale Transdisciplinary Collaborative center for Health Disparities focused on
Precision Medicine (Yale-TCC). ECHORN is a research collaboration funded by the NIMHD
(U2458849938) to address the burden of chronic disease in USVI, PR and the Eastern Caribbean.
The Yale-TCC (U54MD010711) leverages the infrastructure and knowledge of the ECHORN, expands
to include New York and New Jersey and focuses on diabetes and hypertension. The
investigators' network includes community advisory boards as well as policy delegations that
are well suited to inform this project and its expansion into routine healthcare practice and
policy.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01855399 -
Technologically Enhanced Coaching: A Program to Improve Diabetes Outcomes
|
N/A | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Recruiting |
NCT02356848 -
STEP UP to Avert Amputation in Diabetes
|
N/A | |
| Completed |
NCT03292185 -
A Trial to Investigate the Single Dose Pharmacokinetics of Insulin Degludec/Liraglutide Compared With Insulin Degludec and Liraglutide in Healthy Chinese Subjects
|
Phase 1 | |
| Active, not recruiting |
NCT03362528 -
Database and Calibration of a Non-invasive Glucose Monitoring Device
|
N/A | |
| Completed |
NCT02249871 -
Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT01850615 -
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT03288740 -
A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects
|
Phase 1 | |
| Completed |
NCT02911948 -
A Double-blinded Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec Both in Combination With Metformin in Japanese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal or Pre- ix/Combination Insulin Therapy and Oral Anti-diabetic Drugs
|
Phase 3 | |
| Completed |
NCT02461589 -
Dose-finding of Semaglutide Administered Subcutaneously Once Daily Versus Placebo and Liraglutide in Subjects With Type 2 Diabetes
|
Phase 2 | |
| Not yet recruiting |
NCT03661177 -
Reclaiming Indigenous Food and Health
|
N/A | |
| Recruiting |
NCT03675360 -
Low-Carbohydrate Dietary Pattern on Glycemic Outcomes Trial
|
N/A | |
| Not yet recruiting |
NCT03626623 -
Diabetic Foot Ulcer Study Comparing Cytal Wound Matrix 1-Layer to Standard of Care
|
N/A | |
| Not yet recruiting |
NCT03595267 -
Kidney Check: Diabetes, Blood Pressure & Kidney Health Checks & Care in Indigenous Communities.
|
||
| Recruiting |
NCT03065140 -
Muscle Fat Compartments and Turnover as Determinant of Insulin Sensitivity
|
N/A | |
| Recruiting |
NCT02835287 -
Diabetes Complication Control in Community Clinics (D4C) Trial
|
N/A | |
| Enrolling by invitation |
NCT02934113 -
"Working for You" Workplace Obesity Intervention
|
N/A | |
| Completed |
NCT02914730 -
Insulin Dosing Practices in Persons With Diabetes on Multiple Daily Injections
|
||
| Completed |
NCT02916576 -
User Performance Evaluation of Contour® Plus One, Accu-Chek® Performa Connect, FreeStyle Optium Neo and OneTouch® Select Plus Blood Glucose Monitoring Systems Following ISO 15197:2013; EN ISO 15197:2015
|
N/A |
